However, in December 2004 the United States the 14-member Food and Drug Administration (FDA) advisory committee, plus voting consultants, for Reproductive Health Drugs unanimously rejected Procter and Gamble's fast-track request for Intrinsa citing concerns about off-label use . In Canada, post-menopausal women have been able to obtain government-approved testosterone treatment since 2002. In Australia, post-menopausal women can use Organon testosterone implants which have to be surgically inserted and last from three to six months. 
For those wishing a mild steroid cycle, perhaps the best performance-enhancing drug to combine with Primobolan is not another anabolic steroid directly, but HCG at doses totalling approximately 1500 IU/week. This may be taken as, for example, 200 IU daily, 400 IU every other day, or 500 IU three times per week. This typically yields high-normal testosterone levels and maintains normal estrogen levels, aiding the effectiveness of Primobolan with relatively little added androgenic side effects. Such usage may be counted as comparable to injecting 100 mg/week testosterone, and so for example 500 mg/week Primobolan use combined with this amount of HCG may be considered comparable to 600 mg/week total usage of anabolic steroids .